William Maughan
Stock Analyst at Clear Street
(4.49)
# 1,116
Out of 4,659 analysts
146
Total ratings
51.4%
Success rate
17.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Reiterated: Buy | $28 | $11.01 | +154.31% | 8 | Aug 18, 2026 | |
| KRRO Korro Bio | Maintained: Buy | $18 | $13.22 | +36.16% | 6 | Aug 7, 2026 | |
| DNTH Dianthus Therapeutics | Maintained: Buy | $130 | $115.54 | +12.52% | 3 | Aug 5, 2026 | |
| BEAM Beam Therapeutics | Maintained: Buy | $37 | $26.57 | +39.25% | 6 | Aug 5, 2026 | |
| SMMT Summit Therapeutics | Maintained: Buy | $31 | $12.82 | +141.81% | 7 | Jul 27, 2026 | |
| KRYS Krystal Biotech | Maintained: Buy | $338 → $311 | $332.82 | -6.56% | 5 | May 4, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $39 → $36 | $5.29 | +580.53% | 7 | Apr 28, 2026 | |
| ANNX Annexon | Maintained: Buy | $17 | $5.28 | +221.97% | 2 | Mar 30, 2026 | |
| CLLS Cellectis | Maintained: Buy | $9 | $3.04 | +196.05% | 2 | Mar 20, 2026 | |
| IPSC Century Therapeutics | Maintained: Buy | $6.6 | $1.96 | +236.73% | 10 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $4.29 | +86.48% | 4 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $181 → $167 | $92.75 | +80.05% | 21 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.6 | $2.88 | +59.72% | 3 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $11.07 | +306.50% | 4 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $1.56 | +733.33% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $27 | $16.86 | +60.14% | 11 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $50 | $52.97 | -5.61% | 4 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $67 | $36.02 | n/a | 4 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $10.65 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $9 | $2.56 | n/a | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $25.41 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $15 | $2.41 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 → $106 | $62.96 | n/a | 7 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $3.99 | n/a | 7 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $5 | $35.67 | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $212.55 | n/a | 1 | Sep 5, 2022 |
Ocular Therapeutix
Aug 18, 2026
Reiterated: Buy
Price Target: $28
Current: $11.01
Upside: +154.31%
Korro Bio
Aug 7, 2026
Maintained: Buy
Price Target: $18
Current: $13.22
Upside: +36.16%
Dianthus Therapeutics
Aug 5, 2026
Maintained: Buy
Price Target: $130
Current: $115.54
Upside: +12.52%
Beam Therapeutics
Aug 5, 2026
Maintained: Buy
Price Target: $37
Current: $26.57
Upside: +39.25%
Summit Therapeutics
Jul 27, 2026
Maintained: Buy
Price Target: $31
Current: $12.82
Upside: +141.81%
Krystal Biotech
May 4, 2026
Maintained: Buy
Price Target: $338 → $311
Current: $332.82
Upside: -6.56%
Wave Life Sciences
Apr 28, 2026
Maintained: Buy
Price Target: $39 → $36
Current: $5.29
Upside: +580.53%
Annexon
Mar 30, 2026
Maintained: Buy
Price Target: $17
Current: $5.28
Upside: +221.97%
Cellectis
Mar 20, 2026
Maintained: Buy
Price Target: $9
Current: $3.04
Upside: +196.05%
Century Therapeutics
Mar 13, 2026
Maintained: Buy
Price Target: $6.6
Current: $1.96
Upside: +236.73%
Mar 13, 2026
Maintained: Buy
Price Target: $8
Current: $4.29
Upside: +86.48%
Mar 11, 2026
Reiterated: Buy
Price Target: $181 → $167
Current: $92.75
Upside: +80.05%
Mar 10, 2026
Maintained: Buy
Price Target: $4.6
Current: $2.88
Upside: +59.72%
Mar 6, 2026
Reiterated: Buy
Price Target: $45
Current: $11.07
Upside: +306.50%
Mar 6, 2026
Maintained: Buy
Price Target: $13
Current: $1.56
Upside: +733.33%
Feb 26, 2026
Maintained: Buy
Price Target: $29 → $27
Current: $16.86
Upside: +60.14%
Nov 11, 2025
Maintained: Hold
Price Target: $45 → $50
Current: $52.97
Upside: -5.61%
May 23, 2024
Maintained: Hold
Price Target: $67
Current: $36.02
Upside: n/a
May 15, 2024
Maintained: Buy
Price Target: $24
Current: $10.65
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $11 → $9
Current: $2.56
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $38
Current: $25.41
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $16 → $15
Current: $2.41
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: $91 → $106
Current: $62.96
Upside: n/a
Feb 20, 2024
Maintained: Buy
Price Target: $60
Current: $3.99
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $10 → $5
Current: $35.67
Upside: n/a
Sep 5, 2022
Reiterated: Buy
Price Target: n/a
Current: $212.55
Upside: n/a